The hedge fund’s shares of CHS are valued at $26.63 million. CHS makes up about 15.09 percent of Accipiter’s portfolio, according to Trade Calls.
Other hedge funds, including D. E. Shaw, also upped their stakes in CHS in the most recent quarter.
More articles on healthcare finance:
Should providers become payers? 4 key considerations
Calif. denies Saint Agnes Medical Center’s request to lower charity care minimum
AHA urges CMS to delay site-neutral payment policy
Register to Attend Webinar
Presenters:
James Germano, MD, Joint Reconstruction Specialist|Tim Tzimas, Innovative Sterilization Technologies
Next Up in Financial Management
-
Contract breaks between major health systems and certain Medicare Advantage insurers are continuing in 2026. Providers dropping plans often cite…
-
The University of Oklahoma’s Oklahoma City health campus will be renamed after a $150 million gift from energy executive Harold…
-
As the healthcare industry continues to face financial and policy shifts, hospital bankruptcies show no signs of slowing. Becker’s covered…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
